Press Releases

Dr. Vijay Sankaran, a physician-scientist who investigates the molecular underpinnings of pediatric genetic blood disorders, has been awarded the third annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today.

To expand access to life-saving liver transplants for those in need, NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine have unveiled a new living donor liver transplant program. It performed its first such transplant with success in late January.

Mark Veich, an accomplished leader in institutional advancement, has been appointed vice provost for external affairs at Weill Cornell Medicine, effective Feb. 12.

Dr. Said Ibrahim, a leading physician-scientist whose research focuses on healthcare disparities, has been named the inaugural chief of the newly established Division of Healthcare Delivery Science and Innovation in the Department of Healthcare Policy and Research at Weill Cornell Medicine, effective Feb. 1.

Dr. Anthony Hollenberg, a leading physician-scientist specializing in endocrinology, has been appointed chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective Feb. 1.

Weill Cornell Medicine has received a $45.3 million renewal grant from the National Institutes of Health’s Clinical and Translational Science Awards Program to continue funding its multi-institutional Clinical and Translational Science Center until 2022.

Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer research.

A new study finds that it isn’t just the amount of time spent sitting, but also the way in which sitting time is accumulated during the day, that can affect risk of early death.

Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence grant from the National Cancer Institute to improve the detection, diagnosis and treatment of prostate cancer. 

ARCADIA, a multicenter phase III trial, will study the role of abnormalities in the structure and function of the heart’s left atrium, or atrial cardiopathy, in stroke patients, and test a medication that could prevent them from experiencing recurrent strokes.

NewYork-Presbyterian/Weill Cornell Medical Center has been verified as a Level I Adult and a Level II Pediatric Trauma Center by the American College of Surgeons’ Committee on Trauma.

NewYork-Presbyterian Hospital, one of the largest and most comprehensive academic medical centers in the nation, is ranked New York’s No. 1 hospital for the 17th consecutive year, and No. 8 in the United States, according to the U.S. News and World Report annual survey of “Best Hospitals,” published online today.

Dr. Robert Burakoff has been named vice chair for ambulatory services for the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and site chief for the Division of Gastroenterology and Hepatology at NewYork-Presbyterian Lower Manhattan Hospital and Weill Cornell Medicine.

Dr. Ralf Holzer, a pediatric cardiologist and expert in minimally invasive techniques to treat children and adults with congenital heart disease, has been named chief of the Division of Pediatric Cardiology and director of Pediatric Cardiac Catheterization at the Phyllis and David Komansky Center for Children’s Health at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine.

Atrial fibrillation is a condition that affects as many as 6.1 million Americans and is characterized by an irregular, often rapid heart rate caused by a misfiring of electrical impulses. 

A leading scientist and immunologist, Dr. Gary Koretzky has been appointed vice dean, focused on academic integration at Cornell University and Weill Cornell Medicine, effective July 1. Dr. Carl Nathan will succeed Dr. Koretzky as dean of the Weill Cornell Graduate School of Medical Sciences, effective Sept. 1.

Some 30,000 patients enrolled in NewYork Quality Care, the Accountable Care Organization (ACO) of NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine, will now be able to view their physician’s appointment notes in order to better understand their care.

To further realize the promise of precision medicine, Igor Tulchinsky, through WorldQuant, LLC, has made a $5 million gift to Weill Cornell Medicine. 

NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the United States that uses a small molecule to treat men with progressive prostate cancer that has spread beyond the prostate and is no longer responding to hormonal therapy.

 A new weight loss procedure that reduces the size of the stomach without the need for surgery known as endoscopic sleeve gastroplasty (ESG) is safe and effective way for the treatment obesity and obesity-related comorbidities such as diabetes, high blood pressure and fatty liver.